Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate

Clinical Infectious Diseases(2022)10.1093/cid/ciac454Source: DataRank Database

Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.49)OA: greenTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Amy J. Behrman ORCID,Patrick J. Brennan ORCID,Judith A. O’Donnell,Christopher K. Snider ORCID,Krisda H. Chaiyachati ORCID

Live enrichment

PubMed:35666508 PMC:PMC9214168 OpenAlex:https://openalex.org/W4282943565

NIA NIH HHS

Grant: K08 AG065444

National Institutes of Health

Grant: 5K08AG065444-02

Telemedicine Utilization and Impacts on Access Among Rural Medicare Beneficiaries

National Institutes of Health

FWCI

2.49

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9214168

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac454/44470181/ciac454.pdf

publisherhttps://academic.oup.com/cid/article-pdf/76/3/e319/49125045/ciac454.pdf

journalhttps://doi.org/10.1093/cid/ciac454

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingAnimal Virus Infections Studies0301 basic medicine03 medical and health sciences0302 clinical medicineHumansBNT162 VaccineSARS-CoV-2COVID-19VaccinesHealth Personnel2019-nCoV Vaccine mRNA-1273RNARNA, MessengerSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2BNT162 Vaccine2019-nCoV Vaccine mRNA-1273Health PersonnelHumansRNARNA, MessengerVaccines

Keywords

MedicineBooster (rocketry)VaccinationCoronavirus disease 2019 (COVID-19)Booster doseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineImmunologyDiseaseAntibodyInfectious disease (medical specialty)ImmunizationHealthcare WorkerVaccine EffectivenessBoosterSars-cov-2Bnt162b2Mrna1273Omicron VariantVaccinesHealth PersonnelHumansCOVID-19RNARNA, MessengerBNT162 Vaccine2019-nCoV Vaccine mRNA-1273

Sustainable Development Goals

SDG 0: Good health and well-being

Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate

FAIR Checklist

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)